BeStock  
Stocks › Medical Devices › IRMD

IRadimed IRMD

US equityMarket cap rank #3182Medical Devices
$85.47 +$0.65 (+0.77%)
Pre-market · Oct 8, 8:20 am ET · After hours $85.47 0.00%
Open$84.55
Prev close$84.82
Day range$83.84 – $86.77
Volume197.9K
Market cap$1.09B
P/E (TTM)47.7
Dividend yield0.87%

Earnings

Average move on report day±6.9%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+13.4%
Worst reaction-8.4%

Stock move on the day after each report

+9.9%2023/Q3+0.0%2023/Q4+4.4%2024/Q1-1.2%2024/Q2-6.9%2024/Q3-8.4%2024/Q4-2.2%2025/Q1+13.4%2025/Q2+9.5%2025/Q3+9.6%2025/Q4+4.4%2026/Q1-4.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q231 Jul 2026Pre Market±9.2%-4.57%Within range
2026/Q11 May 2026Pre Market±8.1%+4.45%Within range
2025/Q410 Feb 2026Pre Market±6.9%+9.57%Bigger than priced
2025/Q33 Nov 2025Pre Market±9.0%+9.50%Bigger than priced
2025/Q21 Aug 2025Pre Market–+13.42%–
2025/Q15 May 2025Pre Market±11.5%-2.19%Within range
2024/Q413 Feb 2025Pre Market±10.9%-8.39%Within range
2024/Q331 Oct 2024Pre Market–-6.93%–
2024/Q21 Aug 2024Pre Market–-1.20%–
2024/Q12 May 2024Pre Market±8.8%+4.40%Within range
2023/Q48 Feb 2024Pre Market–+0.04%–
2023/Q33 Nov 2023Pre Market±13.4%+9.90%Within range
2023/Q23 Aug 2023Pre Market±8.2%+10.22%Bigger than priced
2023/Q14 May 2023Pre Market±11.1%+7.07%Within range
2022/Q42 Feb 2023Pre Market–+12.49%–
2022/Q33 Nov 2022None–+6.75%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.47M+0.3% YoY
Operating profit$6.39M-5.8% YoY
Net profit$5.22M-9.6% YoY
Diluted EPS$0.41-8.9% YoY
Free cash flow$5.50M+11.7% YoY
Operating cash flow$5.94M

Revenue, last 8 quarters

$18.3MSep '24$19.4MDec '24$19.5MMar '25$20.4MJun '25$21.2MSep '25$22.7MDec '25$22.0MMar '26$20.5MJun '26

Net profit, last 8 quarters

$5.0MSep '24$5.1MDec '24$4.7MMar '25$5.8MJun '25$5.6MSep '25$6.4MDec '25$5.8MMar '26$5.2MJun '26

Profitability & balance sheet

Gross margin75.9%
Operating margin31.9%
Net margin26.7%
Return on equity23.5%
Return on assets20.8%
Return on invested capital23.5%
Current ratio9.46
Liabilities / assets11.5%
Cash & investments$59.08M
Net cash (debt)$59.08M
Free cash flow / sales28.4%

Discussion

No comments yet — be the first to weigh in on IRMD.

Leave a comment

Scroll to Top